INTRODUCTION {#S1}
============

Autophagy is a conserved cellular mechanism required for longevity across phyla ([@R18]). Macroautophagy (hereinafter referred to as autophagy) consists of the bulk sequestration of intracellular material into a vesicle called the autophagosome, which eventually fuses to the lysosome for degradation. Several different age-related diseases, including neurodegenerative diseases, are characterized by autophagic and lysosomal dysfunctions, which result in the accumulation of unprocessed autophagosomes, aberrant organelles, and aggregates ([@R26]; [@R39]). Therefore, to prevent the onset of these age-related diseases, the search for new pharmacological modulators of autophagy is imperative ([@R7]; [@R23]). The transcription factor EB (TFEB) preferentially enhances the expression of autophagy-related and lysosomal genes ([@R32]; [@R34]) and has emerged as an attractive candidate for autophagy modulation. We and others have uncovered a *C. elegans* ortholog of TFEB called HLH-30 ([@R16]; [@R27]; [@R35]; [@R37]). Functional HLH-30 is required for autophagy induction and life-span extension in multiple longevity models ([@R16]) and mediates appropriate transcriptional response during starvation ([@R27]; [@R35]), as well as heat stress and bacterial infection ([@R37]). Nuclear localization of HLH-30/TFEB is controlled by the conserved regulator, the mechanistic target of rapamycin (mTOR) ([@R16]). While mTOR inhibitors activate autophagy in part by enhancing the nuclear localization of TFEB ([@R20]; [@R29]), side effects associated with mTOR inhibition ([@R10]) compel a search for activators of autophagy that are independent of mTOR modulation. Here, we pursued an unbiased approach to find new regulators of the intracellular partitioning of HLH-30/TFEB and uncovered that the conserved gene *Exportin-1 (xpo-1/XPO1)* potently increases the nuclear enrichment of HLH-30/TFEB. Exportins are involved in the nuclear export of proteins, and XPO1 is involved in the recognition and transport of proteins containing leucine-rich nuclear export sequences ([@R6]; [@R14]). In this study, we find that genetic and pharmacological inhibition of XPO-1/XPO1 leads to the nuclear enrichment of HLH-30/TFEB and mTOR-independent autophagic enhancement accompanied by conserved beneficial effects on proteostasis and lifespan.

RESULTS {#S2}
=======

Silencing *xpo-1* Results in Nuclear Enrichment of HLH-30 and Enhanced Autophagy {#S3}
--------------------------------------------------------------------------------

In order to systematically find new autophagy modulators, we performed a genome-wide RNAi screen and searched for genetic modifiers of the nuclear localization of HLH-30/TFEB by following the distribution of HLH-30 fused to GFP ([@R16]; [@R37]). Silencing of *xpo-1*, a conserved ortholog of mammalian *Exportin-1* (*XPO1/CRM-1*) ([Figure S1](#SD1){ref-type="supplementary-material"}), was the most potent inducer of the nuclear localization of HLH-30 ([Figure 1A](#F1){ref-type="fig"}), as enrichment was found in 100% of treated animals, exceeding reported levels in longevity models ([@R16]; [@R25]). Expression of key autophagy genes and HLH-30/TFEB targets, such as *lgg-1* and *lgg-2 (LC3/GABARAP), sqst-1 (SQSTM1/p62)*, and *hlh-30 (TFEB)* were significantly increased upon *xpo-1* silencing ([Figure 1B](#F1){ref-type="fig"}). To assess autophagy directly, we used a tandem autophagy reporter (mCherry::GFP::LGG-1) that measures autophagosome and autolysosome formation ([@R5]). Knockdown of *xpo-1* in wild-type animals enhances autophagosome and autolysosome formation in the pharynx and hypodermal seam cells ([Figures 1C and 1D](#F1){ref-type="fig"}). Silencing *xpo-1* in *hlh-30(tm1978)* mutants failed to enhance autophagy ([Figures 1C and 1D](#F1){ref-type="fig"}), demonstrating a direct role for HLH-30 activity in autophagic induction. Animals subjected to *xpo-1* RNAi displayed increased heat resistance, consistent with a role for enhanced autophagy in heat resistance ([@R13]; [@R37]) ([Figure 1E](#F1){ref-type="fig"} and [Table S1](#SD1){ref-type="supplementary-material"}). Silencing *xpo-1* decreased paralysis in a nematode Alzheimer'smodel expressing Aβ42 ([@R21]) ([Figure 1F](#F1){ref-type="fig"}) and lowered the formation of Huntington's--related polyglutamine protein aggregates (Q35::YFP) ([@R24]; [Figures 1G and 1H](#F1){ref-type="fig"}). Altogether, our data establish a role for the nuclear export protein XPO-1/XPO1 in the modulation of autophagy and proteostasis by regulating the nuclear localization and the activity of HLH-30/TFEB.

Silencing *xpo-1* Results in Lifespan Extension Requiring HLH-30/TFEB, DAF-16/FOXO, and Autophagy {#S4}
-------------------------------------------------------------------------------------------------

Since elevated autophagy is linked to lifespan extension ([@R18]), we sought to determine how reducing *xpo-1* affected life expectancy in *C. elegans*. Silencing *xpo-1* in adult wild-type animals led to a significant lifespan extension ([Figure 2A](#F2){ref-type="fig"}; [Table S1](#SD1){ref-type="supplementary-material"}). Interestingly, *xpo-1* displays antagonistic pleiotropy ([@R11]), as whole-life *xpo-1* knockdown decreased lifespan ([Figure S2A; Table S1](#SD1){ref-type="supplementary-material"}), highlighting developmental roles for XPO-1 followed by a proaging impact in adulthood. Next, we evaluated the contribution of autophagy-related transcription factors and proteins in lifespan extension. Subjecting *hlh-30(tm1978)* or *daf-16(mu86)* mutants to RNAi against *xpo-1* had no effect on their lifespan ([Figures 2B and 2C](#F2){ref-type="fig"}; [Table S1](#SD1){ref-type="supplementary-material"}). DAF-16 was also found localized in the nucleus of animals subjected to *xpo-1* knockdown, suggesting potential co-regulation with HLH-30 ([Figure S2B](#SD1){ref-type="supplementary-material"}). Silencing *xpo-1* in autophagy-defective mutants, *atg-18(gk378)* and *atg-7(bp411)*, did not affect lifespan ([Figures 2D and 2E](#F2){ref-type="fig"}; [Table S1](#SD1){ref-type="supplementary-material"}), demonstrating a requirement for autophagy for the longevity effect associated with *xpo-1* silencing. We found that lifespan extension from *xpo-1* RNAi was not dependent on gonadal signaling using *daf-36(k114)* mutants ([@R30]) ([Figure 2F](#F2){ref-type="fig"}; [Table S1](#SD1){ref-type="supplementary-material"}). To explore the similarities between *xpo-1* silencing and established long-lived models, we silenced *xpo-1* in dietary-restricted *eat- 2(ad1116)*, germline-less *glp-1(e2144)*, and protein-synthesis *rsks-1(sv31)* mutants. Reducing *xpo-1* expression in these mutants had no additive effect on their lifespan, suggesting mechanistic overlap ([Figures 2G--2I](#F2){ref-type="fig"}; [Table S1](#SD1){ref-type="supplementary-material"}). Notably, *xpo-1* mRNA levels were low in these three established longevity models ([Figure S2C](#SD1){ref-type="supplementary-material"}). As observed in several long-lived animals, silencing *xpo-1* resulted in elevated lipid storage ([Figure S2D](#SD1){ref-type="supplementary-material"}) ([@R17]; [@R33]) and increased lysosomal lipase gene expression ([Figure S2E](#SD1){ref-type="supplementary-material"}) ([@R15]; [@R27]; [@R33]; [@R38]). Autophagy gene expression ([Figure 1B](#F1){ref-type="fig"}) was not further enhanced in *glp-1(e2144)* animals subjected to *xpo-1* RNAi ([Figure S2F](#SD1){ref-type="supplementary-material"}). Taken together, our data indicate that lifespan extension from *xpo-1* silencing mechanistically mimics established longevity models and relies on the activity of HLH-30/TFEB and DAF-16/FOXO, as well as functional autophagy.

Pharmacological Inhibition of XPO-1 Extends Lifespan {#S5}
----------------------------------------------------

Recently developed reversible inhibitors of XPO1 have shown selectivity, bioavailability, and a safe toxicity profile in humans. Among these XPO1 inhibitors, the compound KPT-330 (Selinexor, Karyopharm Therapeutics) can cross the blood-brain barrier, which highlights its potential against neurodegenerative diseases ([@R8]). Thus, we tested the effect of XPO-1/XPO1 inhibition by KPT-330 on autophagy and lifespan in *C. elegans*. Day-1 adults subjected to different concentrations (25, 50, and 100 µM) of KPT-330 for 72 hr displayed nuclear localization of HLH-30::GFP ([Figure 3A](#F3){ref-type="fig"}). These concentrations fell within the typical range used in drug screening studies in *C. elegans* ([@R1]; [@R41]). We failed to detect nuclear localization of HLH-30::GFP at concentrations below 25 µM ([Figure S3A](#SD1){ref-type="supplementary-material"}). We observed a significant increase in the lifespan of animals treated with KPT-330 compared to vehicle-treated controls ([Figure 3B](#F3){ref-type="fig"}; [Table S2](#SD1){ref-type="supplementary-material"}). Similarly, nuclear enrichment of HLH-30 and lifespan extension were observed in animals treated with KPT-276 at 25 µM ([Figures S3A and S3B; Table S2](#SD1){ref-type="supplementary-material"}). Animals expressing mCherry:: GFP::LGG-1 were treated with vehicle control or KPT-330 (50 or 100 µM) and visualized after 48 hr. Autophagy was enhanced in pharynx and hypodermal seam cells of drug-treated animals ([Figures 3C and 3D](#F3){ref-type="fig"}). Autophagic increases translated into improved resistance to heat ([Figure 3E](#F3){ref-type="fig"}) and a reduction in the formation of polyglutamine-containing (Q40::YFP) aggregates ([@R22]) ([Figure S3C](#SD1){ref-type="supplementary-material"}). Since KPT-330 was able to extend lifespan in nematodes, we sought to analyze its effect on the lifespan of a Sod1-based neurodegenerative model of amyotrophic lateral sclerosis (ALS) in flies (*dsod^H71Y^*) ([@R31]). Feeding KPT-330 (100 µM) to *dsod^H71Y^* flies during adulthood had a beneficial impact on the overall survivorship compared to control ([Figure 3F](#F3){ref-type="fig"}). Specifically, the lifespan of females, but not of males, was extended significantly ([Figures S3D and S3E; Table S2](#SD1){ref-type="supplementary-material"}), suggesting sex-specific benefits associated with the inhibition of Embargoed/XPO1 and supporting a conserved role for XPO1 in the regulation of proteostasis. Altogether, our data demonstrate that pharmacological inhibition of XPO-1 mimics the effect of *xpo-1* RNAi and protects against neurodegeneration in flies.

XPO1 Inhibition Leads to TFEB Nuclear Enrichment and Autophagy Enhancement {#S6}
--------------------------------------------------------------------------

In order to determine whether the effect of XPO-1/XPO1 inhibition on HLH-30/TFEB and autophagy is conserved in humans, we opted to analyze the effect of XPO1 inhibitors in HeLa cells. Incubating TFEB-GFP-expressing HeLa cells ([@R29]) with various selective inhibitors of nuclear export (KPT-330, KPT-276, KPT-185, and KPT-335) showed a marked increase in nuclear localization of TFEB ([Figures 4A and 4B](#F4){ref-type="fig"}). Similar observations were obtained when cells were incubated with mTOR inhibitor Torin 1, with RNAi against *XPO1*, with GSK-3β inhibitor VIII, or with Leptomycin B ([Figures 4A, 4B](#F4){ref-type="fig"}, [S4A, and S4B](#SD1){ref-type="supplementary-material"}). Enhanced nuclear localization of TFEB was accompanied by marked increase in red Lysotracker signal, corresponding to an increased presence of acidic lysosomal compartments ([Figures 4C and 4D](#F4){ref-type="fig"}). Enhanced Lysotracker signal from mTOR or XPO1 inhibition required TFEB ([Figure S4C](#SD1){ref-type="supplementary-material"}). Levels of both forms of LC3 (I and II) were increased under XPO1 inhibition, suggesting an overall upregulation of autophagosome formation and maturation, as seen with LC3-GFP-expressing cells ([@R19]), but the LC3II/LC3I ratio did not significantly differ from that of control ([Figures 4E, 4F](#F4){ref-type="fig"}, and [S4D](#SD1){ref-type="supplementary-material"}). In contrast to Torin 1, the effect associated with XPO1 inhibition did not rely on reducing mTOR signaling, as phosphorylation of mTOR was not affected by XPO1 inhibition ([Figures 4E](#F4){ref-type="fig"} and [S4E](#SD1){ref-type="supplementary-material"}). Taken together, these results demonstrate a conserved strategy to enhance autophagy and lysosomal function via TFEB nuclear enrichment by inhibiting the conserved nuclear export protein XPO1.

DISCUSSION {#S7}
==========

Our study reveals XPO-1/XPO1 as an evolutionarily conserved modulator of autophagy that regulates the nucleo-cytoplasmic partitioning of HLH-30/TFEB and longevity. Our work highlights the potential for the pharmacological modulation of nuclear export of autophagy-associated transcription factors as an approach for the enhancement of the autophagy process to improve proteostasis and somatic maintenance.

Our unbiased genome-wide RNAi approach identified XPO-1 as a potent regulator of the localization of longevity-associated transcription factors HLH-30/TFEB and DAF-16/FOXO. In addition to providing a strategy to enhance the activity of these transcription factors, our study highlights that their trafficking between cytosolic and nuclear pools is a dynamic process, even in wild-type animals, where these transcription factors are relatively inactive compared to those in long-lived animals ([@R16]). This is consistent with observations that distribution of HLH-30::GFP ([@R16]), and also DAF-16::GFP ([@R2]), does not display nuclear exclusion. The mechanistic overlap between the lifespan associated with *xpo-1* silencing and longevity models such as the germline-less *glp-1(e2144)*, the dietary-restricted *eat-2(ad1116)*, and the protein synthesis mutant *rsks-1(sv31)* support the hypothesis that nuclear enrichment of autophagy-associated transcription factors is a key converging mechanism in modulating longevity. Longevity models may maintain this partitioning by reducing *xpo-1* expression. Altogether, our study demonstrates that genetic or pharmacological induction of nuclear localization of HLH-30/TFEB in conjunction with DAF-16/FOXO is sufficient to increase autophagy and lifespan.

Several proteins rely on XPO1 for nuclear export ([@R36]); as such, our study does not entirely rule out roles outside of HLH-30/TFEB and DAF-16/FOXO in the consequences associated with XPO1 inhibition. For instance, miRNA processing is affected by XPO-1/Embargoed silencing or inhibition ([@R4]). In addition, XPO1 inhibition in mammalian cells slows cancer progression by preventing the XPO-1-mediated export of tumor-suppressing proteins ([@R28]). Here, we demonstrate that HLH-30/TFEB partitioning is modulated by XPO-1/XPO1, consistent with a report suggesting that TFEB is a likely target of XPO1-mediated nuclear export ([@R12]). Specifically, silencing *xpo-1/XPO1* enhances autophagy, lysosome biogenesis, and longevity via HLH-30/TFEB and without affecting mTOR signaling. Proteostatic and longevity benefits associated with the inhibition of XPO1 are conserved as they extend beyond nematodes and into a Sod-1-based model of ALS in *Drosophila*. Our findings are in line with a study in another ALS fly model (C9ORF72) in which KPT-276 was found to reduce neurodegeneration ([@R42]). Together, our findings demonstrate that the use of XPO-1 inhibitors provides an entry point to autophagy and lysosomal regulation by HLH-30/TFEB in an mTOR-independent manner.

Pharmacological modulation of transcription factor function has been relatively challenging ([@R40]). Here, we present a rationale to alter the nucleo-cytoplasmic partitioning of transcription factors associated with autophagy and longevity via XPO1 inhibition. In particular, this approach may be a promising and viable intervention against diseases associated with proteostatic decline, such as neurodegenerative diseases.

EXPERIMENTAL PROCEDURES {#S8}
=======================

Nematode Maintenance {#S9}
--------------------

Strains of *C. elegans* were maintained at 20°C on agar plates seeded with *E. coli* OP50 and handled as previously described ([@R3]). See [Table S3](#SD1){ref-type="supplementary-material"} for a list of strains used.

RNAi Screen {#S10}
-----------

Clones from the Ahringer RNAi library ([@R9]) were used (Source BioScience). HLH-30::GFP-expressing animals were synchronized by bleaching and put on RNAi-seeded agar plates, incubated at 25°C, and visualized on day 1 of adulthood.

Fluorescent Microscopy Imaging {#S11}
------------------------------

Transgenic nematodes were mounted on a 2%agarose pad with 0.1% sodium azide and imaged using a Zeiss Discovery V20 fluorescent microscope.

Gene Expression Analyses {#S12}
------------------------

Nematodes were collected and washed in M9 buffer, and worm pellets were flash frozen with liquid nitrogen. RNA was extracted as described previously ([@R16]). See [Table S4](#SD1){ref-type="supplementary-material"} for details.

Autophagy Analysis {#S13}
------------------

Nematodes expressing the tandem reporter mCherry::GFP::LGG-1 ([@R5]) were treated from day 1 of adulthood and imaged using an LSM 800 Zeiss confocal laser scanning microscope, as previously described ([@R5]).

Proteostasis Analyses {#S14}
---------------------

Heat shock analyses were performed at 37°C, and survival was tracked every hour. Aggregation was visualized by fluorescent microscopy using strains expressing Q35::YFP in muscle (AM140) ([@R24]) or Q40::YFP in intestine (GF78) ([@R22]). Aggregate clearance was assayed with a strain (GMC101) ([@R21]) inducing expression of human Aβ42 at 25°C. Following a 5-day RNAi feeding, paralysis was assayed after 48 hr at 25°C.

Lifespan Analyses {#S15}
-----------------

Nematodes were synchronized by bleaching, and eggs were fed *E. coli* OP50 during development. Day-1 adults were transferred onto agar plates seeded with RNAi-producing bacteria, and survival was assayed at 20°C. Measurement of lifespan at 25°C of *dsod*^H71Y^ flies was performed as previously described ([@R31]).

HeLa Cell Analyses and Immunoblotting {#S16}
-------------------------------------

See the [Supplemental Information](#SD1){ref-type="supplementary-material"} for details on cell culture conditions, imaging, immunoblotting, and statistical analyses.

Supplementary Material {#SM}
======================

[SUPPLEMENTAL INFORMATION](#SD1){ref-type="supplementary-material"}

[Supplemental information](#SD1){ref-type="supplementary-material"} includes four figures, four tables, and [Supplemental Experimental Procedures](#SD1){ref-type="supplementary-material"} and can be found with this article online at <https://doi.org/10.1016/j.celrep.2018.04.063>.
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![XPO-1 Modulates Nuclear Localization of HLH-30/TFEB and Autophagy\
(A) Nematodes expressing HLH-30::GFP were fed control bacteria or bacteria expressing RNAi against *xpo-1* during development or during adulthood for 48 hr (1003 magnification).\
(B) Expression levels of *xpo-1, lgg-1, lgg-2, sqst-1*, and *hlh-30* were measured by qPCR in animals fed control bacteria or bacteria expressing RNAi against *xpo-1* from day 1 to day 5 of adulthood. \*p \< 0.05; \*\*p \< 0.01; n = 4. Error bars represent ± SD, t test.\
(C and D) Autophagosome (AP) and autolysosome (AL) formation was measured in hypodermal seam cells (C) and pharynx (D) of wild-type and *hlh-30(tm1978)* animals expressing tandem autophagy reporter mCherry::GFP::LGG-1 and fed control bacteria or bacteria expressing RNAi against *xpo-1* for 48 hr during early adulthood. \*p \< 0.05; \*\*p \< 0.01; N = 8. Error bars represent ± SD, t test.\
(E) Effect of *xpo-1* silencing during 7 days of adulthood on heat resistance was assayed. p \< 0.05, n = 200, Mantel-Cox log rank. See [Table S1](#SD1){ref-type="supplementary-material"} for statistical analyses and repeats.\
(F--H) Accumulation of Aβ42 (F) and Q35::YFP punctae (Gand H) were measured in transgenic animals fed control bacteria or bacteria expressing RNAi against *xpo-1* during 5 days of adulthood; images are shown in (G), and quantification is given in (H). \*p \< 0.05. Q35::YFP, n = 5; Aβ42, n = 100. Error bars represent ± SD, t test.](nihms970665f1){#F1}

![Silencing *xpo-1* Extends Lifespan in *C. elegans*\
(A--I) Lifespan analyses of (A) wild-type (WT), (B) *hlh-30(tm1978)*, (C) *daf-16(mu86)*, (D) *atg-7(bp411)*, (E) *atg-18(gk378)*, (F) *daf-36(k114)*, (G) *glp-1(e2144),* (H) *eat-2(ad1116)*, and (I) *rsks-1(sv31)* fed control bacteria or bacteria expressing RNAi against *xpo-1* from day 1 of adulthood. n = 100, Mantel-Cox log rank.\
See also [Table S1](#SD1){ref-type="supplementary-material"} for statistical analyses and repeats.](nihms970665f2){#F2}

![Pharmacological Inhibition of XPO-1/Embargoed Promotes Autophagy and Longevity\
(A) Day 1 animals expressing HLH-30::GFP were fed *E. coli* OP50 bacteria with DMSO (0.1%) or KPT-330 (25, 50, or 100 µM). 100× magnification.\
(B) Lifespan analysis of wild-type animals fed bacteria with DMSO (0.1%) or KPT-330 (25, 50, or 100 µM).\
(C and D) Autophagosome (AP) and autolysosome (AL) were quantified in the pharynx (C) and in hypodermal seam cells (D) of animals expressing mCherry::GFP::LGG-1 and fed bacteria with DMSO (0.1%) or KPT-330 (50 or 100 µM) from day 1 to day 3 of adulthood. \*\*p \< 0.01; n = \~10. Error bars represent ± SD, t test.\
(E) Heat stress assay of animals fed bacteria with DMSO (0.1%) or KPT-330 (100 µM) from day 1 to day 5 of adulthood. p \< 0.05; n\~100.\
(F) Lifespan analysis of the ALS model in flies (*dsod^H71Y^*) fed food with DMSO (0.1%) or KPT-330 (100 µM). p \< 0.05; n \> 300, Mantel-Cox log rank.\
See [Table S2](#SD1){ref-type="supplementary-material"} for statistical analyses and repeats.](nihms970665f3){#F3}

![Nuclear Enrichment of TFEB and Autophagy Are Stimulated by XPO1 Inhibition\
(A) TFEB-GFP-expressing HeLa cells were imaged after incubation for 6 hr in a medium containing vehicle or compounds (Torin 1, 5 µM; KPTs, 1 µM). Scale bars, 20 µm.\
(B) Percentage of cells with TFEB nuclear localization was quantified from four independent experiments. \*\*\*p \< 0.001. Error bars represent ± SD, t test.\
(C and D) HeLa cells were grown in medium containing vehicle or compounds for 6 hr, lysosomes were visualized with Lysotracker Red (C), and signal intensities were quantified (D). \*\*p \< 0.01; \*\*\*p \< 0.001. Scale bars, 50 µm. ^\#^Image taken at half the exposure for representational purposes.\
(E) HeLa cells were grown in a medium containing vehicle or compounds for 24 hr, and proteins were visualized by immunoblotting.\
(F) Levels of LC3 I and II were quantified by densitometry. \*p \< 0.05; \*\*p \< 0.01; \*\*\*p \< 0.001.\
Error bars represent ± SD, one-way ANOVA.\
Images and blots are representative of three independent experiments.](nihms970665f4){#F4}

###### Highlights

-   Reducing XPO-1/XPO1 increases nuclear HLH-30/TFEB and stimulates autophagy

-   Lifespan extension by *xpo-1* silencing mechanistically mimics longevity models

-   Selective inhibitors of nuclear export (SINEs) extend lifespan in worms and flies

-   SINEs enhance autophagy and lysosomal biogenesis without affecting mTOR signaling

[^1]: These authors contributed equally

[^2]: Lead Contact
